{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:57:18Z","timestamp":1794477438858,"version":"4.9.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012895","name":"Zoetis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.tvjl.2026.106635","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:35:18Z","timestamp":1774514118000},"page":"106635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Laboratory safety evaluations of izenivetmab, a caninized anti-nerve growth factor monoclonal antibody, for three-month alleviation of osteoarthritic pain in dogs"],"prefix":"10.1016","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7472-4095","authenticated-orcid":false,"given":"Adam","family":"Werts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Mangus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Bedard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogely","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Knauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4995-0413","authenticated-orcid":false,"given":"Sarah","family":"Roode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phaedra","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2026.106635_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.695592","article-title":"Nerve growth factor biodelivery: a limiting step in moving toward extensive clinical application?","volume":"15","author":"Alastra","year":"2021","journal-title":"Frontiers in Neuroscience"},{"issue":"3","key":"10.1016\/j.tvjl.2026.106635_bib2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2174\/1570159X13666150403231920","article-title":"Nerve growth factor: a focus on neuroscience and therapy","volume":"13","author":"Aloe","year":"2015","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/j.tvjl.2026.106635_bib3","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2147\/JPR.S247472","article-title":"Nerve growth factor signaling and its contribution to pain","volume":"13","author":"Barker","year":"2020","journal-title":"Journal of Pain Research"},{"issue":"2","key":"10.1016\/j.tvjl.2026.106635_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/toxsci\/kfx089","article-title":"Evaluation of the effects of tanezumab, a monoclonal antibody against nerve growth factor, on the sympathetic nervous system in adult cynomolgus monkeys (Macaca fascicularis): a stereologic, histomorphologic, and cardiofunctional assessment","volume":"158","author":"Belanger","year":"2017","journal-title":"Toxicological Sciences"},{"issue":"8","key":"10.1016\/j.tvjl.2026.106635_bib5","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/01926233221135563","article-title":"Scientific and regulatory policy committee best practices: recommended (\"best\") practices for informed (non-blinded) versus masked (blinded) microscopic evaluation in animal toxicity studies","volume":"50","author":"Bolon","year":"2022","journal-title":"Toxicologic Pathology"},{"key":"10.1016\/j.tvjl.2026.106635_bib6","doi-asserted-by":"crossref","unstructured":"Budsberg, S., Innes, J., Berenbaum, F., Knesl, O., Monteiro, B., Werts, A., 2025. Response to: Iff, I., Hohermuth, B., Bass, D., Bass, M., 2025. A case of potential rapidly progressing osteoarthritis (RPOA) in a dog during bedinvetmab treatment. Vet Anesth. Analg. 52, 263\u2013265. Letter to the Editor. 52 (3) 372-374.","DOI":"10.1016\/j.vaa.2025.03.002"},{"key":"10.1016\/j.tvjl.2026.106635_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1137888","article-title":"COAST Development Group's international consensus guidelines for the treatment of canine osteoarthritis","volume":"10","author":"Cachon","year":"2023","journal-title":"Frontiers in Veterinary Science"},{"key":"10.1016\/j.tvjl.2026.106635_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/biology13070546","article-title":"Multifaceted roles of nerve growth factor: a comprehensive review with a special insight into pediatric perspectives","volume":"13","author":"Capossela","year":"2024","journal-title":"Biology"},{"key":"10.1016\/j.tvjl.2026.106635_bib9","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.joca.2023.08.010","article-title":"Characterization of adverse joint outcomes in patients with osteoarthritis treated with subcutaneous tanezumab","volume":"31","author":"Carrino","year":"2023","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.tvjl.2026.106635_bib10","first-page":"373","article-title":"Anti-nerve growth factor in pain management: current evidence","volume":"9","author":"Chang","year":"2016","journal-title":"Journal of Pain Research"},{"key":"10.1016\/j.tvjl.2026.106635_bib11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrn1078","article-title":"Neurotrophins and their receptors: a convergence point for many signaling pathways","volume":"4","author":"Chao","year":"2003","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.tvjl.2026.106635_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105329","article-title":"Re-evaluating the need for chronic toxicity studies with therapeutic monoclonal antibodies, using a weight of evidence approach","volume":"138","author":"Chien","year":"2023","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.tvjl.2026.106635_bib13","series-title":"Guidelines for preparing Core clinical-safety information on drugs","author":"CIOMS Working Groups III and IV","year":"1999"},{"issue":"4","key":"10.1016\/j.tvjl.2026.106635_bib14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.molmed.2020.11.006","article-title":"Permeability of the endothelial barrier: identifying and reconciling controversies","volume":"27","author":"Claesson-Welsh","year":"2021","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.tvjl.2026.106635_bib15","unstructured":"Cole, P., Tonissen, S., Bedard, A., 2024. Background findings of infrequently examined bones in Beagle dogs. 43rd Annual Symposium of the Society of Toxicologic Pathology, Poster."},{"issue":"3","key":"10.1016\/j.tvjl.2026.106635_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101568","article-title":"High-affinity TrkA and p75 neurotrophin receptor complexes: a twisted affair","volume":"298","author":"Conroy","year":"2022","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.tvjl.2026.106635_bib17","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.joca.2010.04.017","article-title":"The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the dog","volume":"18","author":"Cook","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"issue":"6","key":"10.1016\/j.tvjl.2026.106635_bib18","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.vaa.2021.08.001","article-title":"A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis","volume":"48","author":"Corral","year":"2021","journal-title":"Veterinary Anaesthesia and Analgesia"},{"key":"10.1016\/j.tvjl.2026.106635_bib19","series-title":"Practical Guide to Canine and Feline Neurology","first-page":"9","article-title":"Performing the neurologic examination","author":"Dewey","year":"2015"},{"issue":"6","key":"10.1016\/j.tvjl.2026.106635_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jveb.2014.08.007","article-title":"Behavior of laboratory beagles towards humans: assessment in an encounter test and a simulation of experimental situations","volume":"9","author":"D\u00f6ring","year":"2014","journal-title":"Journal of Veterinary Behavior"},{"issue":"3","key":"10.1016\/j.tvjl.2026.106635_bib21","first-page":"1","article-title":"Publication of registration studies for veterinary medicine in peer-reviewed academic journals","volume":"9","author":"Elliot","year":"2024","journal-title":"Veterinary Evidence"},{"key":"10.1016\/j.tvjl.2026.106635_bib22","unstructured":"EMA, 2021. Assessment report, Raylumis, International non-proprietary name: tanezumab. URL \u3008https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/raylumis-epar-refusal-public-assessment-report_en.pdf\u3009 (accessed 06\/13\/2025)."},{"issue":"10","key":"10.1016\/j.tvjl.2026.106635_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/vetr.516","article-title":"Defining the rate of, and factors influencing, radiographic progression of osteoarthritis of the canine hip joint","volume":"89","author":"Enomoto","year":"2021","journal-title":"Vet Rec"},{"issue":"1","key":"10.1016\/j.tvjl.2026.106635_bib24","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1038\/s41598-024-52324-9","article-title":"Prevalence of radiographic appendicular osteoarthritis and associated clinical signs in young dogs","volume":"14","author":"Enomoto","year":"2024","journal-title":"Scientific Reports"},{"key":"10.1016\/j.tvjl.2026.106635_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/vr.104590","article-title":"Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats","volume":"184","author":"Enomoto","year":"2019","journal-title":"Vet Rec"},{"key":"10.1016\/j.tvjl.2026.106635_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.autneu.2019.02.004","article-title":"Effects of tanezumab on satellite glial cells in the cervicothoracic ganglion of cynomolgus monkeys: a 26-week toxicity study followed by an 8-week recovery period","volume":"218","author":"Evans","year":"2019","journal-title":"Autonomic Neuroscience Basic and Clinical"},{"key":"10.1016\/j.tvjl.2026.106635_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2025.1581490","article-title":"Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela)","volume":"12","author":"Farrell","year":"2025","journal-title":"Frontiers in Veterinary Science"},{"key":"10.1016\/j.tvjl.2026.106635_bib28","unstructured":"FDA Standard Adverse Event Review for Librela, 2024. URL \u3008https:\/\/www.fda.gov\/media\/184483\/download?attachment\u3009 (accessed on 06\/12\/2024)."},{"key":"10.1016\/j.tvjl.2026.106635_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11926-017-0665-5","article-title":"Rapidly progressive osteoarthritis: a review of the clinical and radiologic presentation","volume":"19","author":"Flemming","year":"2017","journal-title":"Current Rheumatology Reports"},{"key":"10.1016\/j.tvjl.2026.106635_bib30","unstructured":"Galliprant, Prescribing Information, 2024. URL \u3008https:\/\/my.elanco.com\/us\/galliprant\u3009. https:\/\/assets-us- 01.kc-usercontent.com\/e4748d51-2c24-00f7-fc54-65f3864ee8b1\/ec2e9806-1dfb-4f05-aa66- 07ad7ad74289\/PROMO_WEB_104149As_PA104149X_W1b_WS.pdf (accessed on 07\/21\/2025)."},{"issue":"3","key":"10.1016\/j.tvjl.2026.106635_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/0192623308315670","article-title":"Spontaneous and age-related testicular findings in beagle dogs","volume":"36","author":"Goedken","year":"2008","journal-title":"Toxicologic Pathology"},{"issue":"4","key":"10.1016\/j.tvjl.2026.106635_bib32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.phrs.2010.12.017","article-title":"NGF and heart: is there a role in heart disease?","volume":"63","author":"Govoni","year":"2011","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.tvjl.2026.106635_bib33","article-title":"Efficacy and safety of an anti-nerve growth factor antibody (Frunevetmab) for the treatment of degenerative joint disease-associated chronic pain in cats: a multisite pilot field study","volume":"8","author":"Gruen","year":"2021","journal-title":"Frontiers in Veterinary Science Comparative and Clinical Medicine"},{"issue":"1","key":"10.1016\/j.tvjl.2026.106635_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2133\/dmpk.DMPK-10-RV-062","article-title":"Mechanisms of drug toxicity and relevance to pharmaceutical development","volume":"26","author":"Guengerich","year":"2011","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.tvjl.2026.106635_bib35","unstructured":"Guidance for Industry #226, 2016. URL \u3008https:\/\/www.fda.gov\/media\/91376\/download\u3009 (accessed on 07\/21\/2025)."},{"issue":"3","key":"10.1016\/j.tvjl.2026.106635_bib36","first-page":"304","article-title":"Association of rapidly destructive osteoarthritis of the hip with intra-articular steroid injections","volume":"4","author":"Hess","year":"2018","journal-title":"Arthroplasty Today"},{"key":"10.1016\/j.tvjl.2026.106635_bib37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/papr.12342","article-title":"NGF\/TrkA signaling as a therapeutic target for pain","volume":"16","author":"Hirose","year":"2016","journal-title":"Pain Practice"},{"issue":"7","key":"10.1016\/j.tvjl.2026.106635_bib38","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/art.41674","article-title":"Long-term safety and efficacy of subcutaneous tanezumab versus nonsteroidal antiinflammatory drugs for hip or knee osteoarthritis: a randomized trial","author":"Hochberg","year":"2021","journal-title":"Arthritis and Rheumatorlogy 3"},{"issue":"3","key":"10.1016\/j.tvjl.2026.106635_bib39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.devcel.2016.10.003","article-title":"Neurotrophin signaling is required for glucose-induced insulin secretion","volume":"39","author":"Houtz","year":"2016","journal-title":"Dev Cell"},{"key":"10.1016\/j.tvjl.2026.106635_bib40","first-page":"183","article-title":"An analysis of the relative frequencies of reported adverse events associated with NSAID administration in dogs and cats in the United Kingdom","volume":"206","author":"Hunt","year":"2015"},{"key":"10.1016\/j.tvjl.2026.106635_bib41","series-title":"Preclinical safety evaluation of biotechnology-derived pharmaceuticals; Committee for medicinal products for human use (CHMP)","author":"ICH guideline S6 (R1)","year":"2011"},{"issue":"22","key":"10.1016\/j.tvjl.2026.106635_bib42","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/CIRCULATIONAHA.106.627588","article-title":"Nerve growth factor is critical for cardiac sensory innervation and rescues neuropathy in diabetic hearts","volume":"114","author":"Ieda","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.tvjl.2026.106635_bib43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.vaa.2024.11.041","article-title":"A case of potential rapidly progressing osteoarthritis (RPOA) in a dog during bedinvetmab treatment","volume":"52","author":"Iff","year":"2024","journal-title":"Veterinary Anaesthesia and Analgesia"},{"key":"10.1016\/j.tvjl.2026.106635_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2025.1502218","article-title":"A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis","volume":"12","author":"Innes","year":"2025","journal-title":"Frontiers in Veterinary Science"},{"key":"10.1016\/j.tvjl.2026.106635_bib45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3415\/VCOT-10-04-0051","article-title":"Nerve growth factor concentrations in the synovial fluid from healthy dogs and dogs with secondary osteoarthritis","volume":"24","author":"Isola","year":"2011","journal-title":"Veterinary and Comparative Orthopaedics and Traumatology"},{"key":"10.1016\/j.tvjl.2026.106635_bib46","first-page":"699","article-title":"Osteoarthritis: joint anatomy, physiology, and pathobiology","volume":"27","author":"Johnson","year":"1997","journal-title":"Veterinary Clinics: Small Animal Practice"},{"issue":"3","key":"10.1016\/j.tvjl.2026.106635_bib47","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/jvim.16718","article-title":"Serum nerve growth factor in horses with osteoarthritis-associated lameness","volume":"37","author":"Kendall","year":"2023","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2026.106635_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvjl.2021.105733","article-title":"Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs","volume":"276","author":"Krautmann","year":"2021","journal-title":"The Veterinary Journal"},{"issue":"2","key":"10.1016\/j.tvjl.2026.106635_bib49","first-page":"283","article-title":"Clinical applications of NGF in ocular diseases","volume":"149","author":"Lambiase","year":"2011","journal-title":"Archives Italiennes"},{"key":"10.1016\/j.tvjl.2026.106635_bib50","first-page":"237","article-title":"Guidelines for safe and effective use of NSAIDs in dogs","volume":"6","author":"Lascelles","year":"2005","journal-title":"Veterinary therapeutics"},{"issue":"1","key":"10.1016\/j.tvjl.2026.106635_bib51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.yrtph.2014.02.008","article-title":"The T-cell-dependent antibody response assay in nonclinical studies of pharmaceuticals and chemicals: study design, data analysis, interpretation","volume":"69","author":"Lebrec","year":"2014","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.tvjl.2026.106635_bib52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-3-642-45106-5_10","article-title":"Nerve growth factor and nociception: from experimental embryology to new analgesic therapy","volume":"220","author":"Lewin","year":"2014","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"1","key":"10.1016\/j.tvjl.2026.106635_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s13238-017-0408-4","article-title":"Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins","volume":"9","author":"Liu","year":"2018","journal-title":"Protein Cell"},{"issue":"6","key":"10.1016\/j.tvjl.2026.106635_bib54","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3892\/etm.2021.10031","article-title":"Role of NGF and its receptors in wound healing","volume":"21","author":"Liu","year":"2021","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1016\/j.tvjl.2026.106635_bib55","article-title":"All smoke and no light \u2013 basic errors and methodological flaws in a study of adverse events in dogs receiving bedinvetmab (LibrelaTM)","volume":"2025","author":"Lloyd","year":"2025","journal-title":"Frontiers in Veterinary Science"},{"issue":"11","key":"10.1016\/j.tvjl.2026.106635_bib56","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/jps.20178","article-title":"Antibody pharmacokinetics and pharmacodynamics","volume":"93","author":"Lobo","year":"2004","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"4","key":"10.1016\/j.tvjl.2026.106635_bib57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/abt\/tbac021","article-title":"The global landscape of approved antibody therapies","volume":"5","author":"Lyu","year":"2022","journal-title":"Antibody therapy"},{"key":"10.1016\/j.tvjl.2026.106635_bib58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/ALN.0b013e31821b1ac5","article-title":"Antagonism of nerve growth factor-TrkA signaling and the relief of pain","volume":"115","author":"Mantyh","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.tvjl.2026.106635_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1201328","article-title":"Anti-NGF treatment worsens subchondral bone and cartilage measures while improving symptoms in floor-housed rabbits with osteoarthritis","volume":"14","author":"Menges","year":"2023","journal-title":"Frontiers in Physiology"},{"issue":"5","key":"10.1016\/j.tvjl.2026.106635_bib60","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.vaa.2023.06.003","article-title":"A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody","volume":"50","author":"Michels","year":"2023","journal-title":"Veterinary Anaesthesia and Analgesia"},{"issue":"5","key":"10.1016\/j.tvjl.2026.106635_bib61","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/ijms18051028","article-title":"NGF and its receptors in the regulation of inflammatory response","volume":"18","author":"Minnone","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.tvjl.2026.106635_bib62","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/cancers3010510","article-title":"Nerve growth factor in cancer cell death and survival","volume":"3","author":"Molloy","year":"2011","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.tvjl.2026.106635_bib63","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1515\/hsz-2016-0280","article-title":"\u03b2-NGF and \u03b2-NGF receptor upregulation in blood and synovial fluid in osteoarthritis","volume":"398","author":"Montagnoli","year":"2017","journal-title":"Biological Chemistry"},{"key":"10.1016\/j.tvjl.2026.106635_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2025.1558222","article-title":"Global pharmacovigilance reporting of the first monoclonal antibody for canine osteoarthritis: a case study with bedinvetmab (Librela\u2122)","volume":"12","author":"Monteiro","year":"2025","journal-title":"Frontiers in Veterinary Science"},{"issue":"7","key":"10.1016\/j.tvjl.2026.106635_bib65","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1177\/0192623310383991","article-title":"Recommendations for Pathology Peer Review","volume":"38","author":"Morton","year":"2010","journal-title":"Toxicologic Pathology"},{"key":"10.1016\/j.tvjl.2026.106635_bib66","unstructured":"NSAIDs), 2024. URL \u3008https:\/\/www.fda.gov\/animal-veterinary\/product-safety-information\/veterinary-nonsteroidal-anti-inflammatory-drugs-nsaids\u3009 (accessed on 06\/05\/2024)."},{"issue":"22","key":"10.1016\/j.tvjl.2026.106635_bib67","first-page":"2070","article-title":"Rapidly destructive hip disease following intra-articular corticosteroid injection of the hip","volume":"103","author":"Okike","year":"2021","journal-title":"The Journal of Bone and Joint Surgery"},{"issue":"7","key":"10.1016\/j.tvjl.2026.106635_bib68","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2460\/ajvr.1983.44.07.1300","article-title":"Degenerative joint disease: multiple joint involvement in young and mature dogs","volume":"44","author":"Olsewski","year":"1983","journal-title":"American Journal of Veterinary Research"},{"issue":"6","key":"10.1016\/j.tvjl.2026.106635_bib69","first-page":"1243","article-title":"An update on nonsteroidal anti-inflammatory drugs (NSAIDs) in small animals","volume":"38","author":"Papich","year":"2008","journal-title":"Veterinary Clinics: Small Animal Practice"},{"issue":"4","key":"10.1016\/j.tvjl.2026.106635_bib70","doi-asserted-by":"crossref","DOI":"10.1172\/JCI183873","article-title":"Neuropilin-1 inhibition suppresses nerve growth factor signaling and nociception in pain models","volume":"135","author":"Peach","year":"2025","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.tvjl.2026.106635_bib71","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/15476910500362838","article-title":"T-cell-dependent antibody response: assay development in cynomolgus monkeys","volume":"2","author":"Piccotti","year":"2005","journal-title":"Journal of Immunotoxicology"},{"issue":"2","key":"10.1016\/j.tvjl.2026.106635_bib72","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3928\/01477447-20130122-04","article-title":"Differentiation, diagnosis, and treatment of osteoarthritis, osteonecrosis, and rapidly progressive osteoarthritis","volume":"36","author":"Pivec","year":"2013","journal-title":"Orthopedics"},{"key":"10.1016\/j.tvjl.2026.106635_bib73","unstructured":"Rimadyl, Prescribing Information, 2019. URL \u3008https:\/\/www.zoetisus.com\/content\/_assets\/docs\/vmips\/package-inserts\/rimadyl-chewable-tablets-prescribing-information.pdf\u3009 (accessed 06\/19\/2025)."},{"issue":"9","key":"10.1016\/j.tvjl.2026.106635_bib74","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/psp4.12224","article-title":"Pharmacokinetics of monoclonal antibodies","volume":"6","author":"Ryman","year":"2017","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.tvjl.2026.106635_bib75","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/vr.164.14.418","article-title":"Systematic review of the management of canine osteoarthritis","volume":"164","author":"Sanderson","year":"2009","journal-title":"Vet Rec"},{"key":"10.1016\/j.tvjl.2026.106635_bib76","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40122-024-00592-8","article-title":"Clinical assessment of osteoarthritis pain: contemporary scenario, challenges, and future perspectives","volume":"13","author":"Sethi","year":"2024","journal-title":"Pain and Therapy"},{"issue":"2","key":"10.1016\/j.tvjl.2026.106635_bib77","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4161\/mabs.23684","article-title":"Antibody biodistribution coefficients. Inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human","volume":"5","author":"Shah","year":"2013","journal-title":"mAbs"},{"issue":"ement 1","key":"10.1016\/j.tvjl.2026.106635_bib78","doi-asserted-by":"crossref","first-page":"S280","DOI":"10.1016\/j.joca.2019.02.663","article-title":"Do non-steroidal anti- inflammatory drugs cause osteoarthritis progression? A systematic review and meta-analysis","volume":"27","author":"Simic","year":"2019","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/j.tvjl.2026.106635_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2025.1663398","article-title":"Commentary: musculoskeletal adverse events in dogs receiving bedinvetmab (Librela)","volume":"12","author":"Simon","year":"2025","journal-title":"Frontiers in Veterinary Science"},{"key":"10.1016\/j.tvjl.2026.106635_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvjl.2022.105868","article-title":"Relationships among owner consideration of euthanasia, caregiver burden, and treatment satisfaction in canine osteoarthritis","volume":"286","author":"Spitznagel","year":"2022","journal-title":"The Veterinary Journal"},{"issue":"3","key":"10.1016\/j.tvjl.2026.106635_bib81","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1208\/s12248-019-0304-3","article-title":"Pharmacokinetic Properties of Humanized IgG1 and IgG4 Antibodies in Preclinical Species: translational Evaluation","volume":"21","author":"Tabrizi","year":"2019","journal-title":"Aaps Journal"},{"issue":"11","key":"10.1016\/j.tvjl.2026.106635_bib82","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101760RR","article-title":"Disentangling the signaling complexity of nerve growth factor receptors by CRISPR\/Cas9","volume":"36","author":"Testa","year":"2022","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.tvjl.2026.106635_bib83","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/JPR.S191297","article-title":"Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip","volume":"12","author":"Tive","year":"2019","journal-title":"Journal of Pain Research"},{"key":"10.1016\/j.tvjl.2026.106635_bib84","unstructured":"VICH GL43, Target Animal Safety for Veterinary Pharmaceutical Products, 2009. URL \u3008https:\/\/www.fda.gov\/files\/animal%20%26%20veterinary\/published\/CVM-GFI--185-%28VICH-GL43%29-Target-Animal-Safety-for-Veterinary-Pharmaceutical-Products.pdf\u3009 (accessed on 06\/12\/2025)."},{"key":"10.1016\/j.tvjl.2026.106635_bib85","unstructured":"VICH GL44, Target Animal Safety for Veterinary Live and Inactivated Vaccines, 2008. URL \u3008https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/vich-gl44-target-animal-safety-veterinary-live-and-inactived-vaccines-step-7_en.pdf\u3009 (accessed on 06\/12\/2025)."},{"issue":"4","key":"10.1016\/j.tvjl.2026.106635_bib86","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/ani15040472","article-title":"Current review of monoclonal antibody therapeutics in small animal medicine","volume":"15","author":"Wang","year":"2025","journal-title":"Animals"},{"issue":"7","key":"10.1016\/j.tvjl.2026.106635_bib87","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.3390\/ijms23073645","article-title":"Vascular permeability in diseases","volume":"23","author":"Wautier","year":"2022","journal-title":"International Journal of Molecular Sciences"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023326000912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023326000912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T01:14:49Z","timestamp":1780017289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023326000912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":87,"alternative-id":["S1090023326000912"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2026.106635","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laboratory safety evaluations of izenivetmab, a caninized anti-nerve growth factor monoclonal antibody, for three-month alleviation of osteoarthritic pain in dogs","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2026.106635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106635"}}